Table of Contents Table of Contents
Previous Page  105 / 363 Next Page
Information
Show Menu
Previous Page 105 / 363 Next Page
Page Background

© 2015 AOAC INTERNATIONAL

AOAC Official Method 2015.09

Trans

Vitamin K

1

in Infant, Pediatric, and Adult Nutritionals

HPLC with Fluorescence Detection

First Action 2015

(Applicable to the determination of

trans

vitamin K

1

in infant,

pediatric, and adult nutritional formulas.)

Caution

: Refer to Material Safely Data Sheets (MSDS) of

chemicals prior to use and use the suggested personal

protective equipment. Zinc powder should be handled in

a fume hood; it is self-heating and may catch fire. Zinc

powder should not be allowed to come into contact with

water, which may release flammable gases that may

spontaneously ignite.

See

Tables

2015.09A

and

B

for infant, pediatric, and nutritional

matrixes for which the method has been validated; and for study

results supporting acceptance of the method.

A. Principle

This normal-phase (NP) HPLC method with postcolumn

reduction and fluorescence detection allows for the quantitative

determination of

trans

vitamin K

1

in infant, pediatric, and adult

nutritionals. Vitamin K

1

is extracted from products with iso-octane

after precipitation of proteins and release of lipids with methanol.

Prepared samples are injected onto a silica HPLC column where

cis

and

trans

vitamin K

1

are separated with an iso-octane–isopropanol

mobile phase. The column eluent is mixed with a dilute ethanolic

solution of zinc chloride, sodium acetate, and acetic acid, and

vitamin K

1

is reduced to a fluorescent derivative in a zinc reactor

column. The resulting fluorescent compound is then detected by

fluorescence at an excitation wavelength of 245 nm and an emission

wavelength of 440 nm.

B. Apparatus and Materials

(a) 

HPLC system

.—Two isocratic pumps; autosampler capable

of injecting 20 µL; fluorescence detector; high-pressure mixing tee;

and postcolumn reactor column 20 × 4 mm stainless steel (Waters,

Milford, MA, USA; Part No. WAT084550 or equivalent). The

system should be configured as shown in Figure

2015.09A

.

(b) 

Analytical column

.—Silica 150 × 3.0 mm, 3 µm, 60 Å, or

equivalent.

(c) 

Analytical balance

.—Capable of weighing to the nearest

0.00001 g.

(d) 

Beakers

.—Glass, assorted sizes.

(e) 

Centrifuge

.

(f) 

Centrifuge tubes and caps

.—50 mL glass tubes with Teflon-

lined caps.

(g) 

Cylinders

.—Graduated, glass, assorted sizes.

(h) 

Gas regulator

.—Helium.

(i) 

Helium sparge

.—Tubing and filtering assembly.

(j) 

Magnetic stirrer.—

Variomag Telesystem (Daytona Beach,

FL, USA) HP 60 S (Part No. HP 46040U) with tube rack (Part

No. HP 86029) and egg-shaped Teflon stirring bars (Part No.

PI20110) or equivalent.

(k) 

Pipet.—

Disposable glass, Pasteur.

(l) 

Pipet.—

Mechanical, variable volume, 0.5–5 mL and

10–100 µL.

(m) 

Pipet

.—Repeating 5 and 25 mL or equivalent.

(n) 

Volumetric flasks.—

Glass, Class A, assorted sizes.

(o) 

Volumetric pipets.—

Glass, Class A, assorted sizes.

(p) 

Vortex mixers

.

(q) 

Yellow lights or yellow shields with cutoff of at least 440 nm

.

C. Reagents

(a) 

Acetic acid

.—Glacial, ACS.

(b) 

Helium

.—Zero grade or equivalent

.

(c) 

Iso-octane (2,2,4-trimethylpentane)

.—HPLC grade.

Table 2015.09A. 

Trans

vitamin K

1

SLV data—precision

Sample type

No. of replicates

(duplicates on multiple days)

Mean, µg/100 g

RTF

SD

r

RSD

r

, % SD

IP

RSD

IP

, %

Child formula powder, placebo

6

2.03

0.040

2.0

0.045

2.2

Infant elemental powder, placebo

6

2.03

0.020

1.0

0.025

1.2

Adult nutritional RTF high protein, placebo

6

3.47

0.021

0.6

0.040

1.2

Adult nutritional RTF high fat, placebo

6

3.07

0.034

1.1

0.034

1.1

Infant formula RTF milk based, placebo

6

2.16

0.038

1.8

0.038

1.8

SRM 1849a

12

1.11

a

0.022

2.0

0.025

2.3

Adult nutritional powder milk protein based

12

3.26

0.097

3.0

0.142

4.4

Infant formula powder partially hydrolyzed milk based

12

7.69

0.123

1.6

0.170

2.2

Infant formula powder partially hydrolyzed soy based

12

8.99

0.141

1.6

0.226

2.5

Adult nutritional powder low fat

12

2.92

0.102

3.5

0.102

3.5

Child formula powder

12

2.66

0.049

1.8

0.050

1.9

Infant elemental powder

12

7.57

0.129

1.7

0.451

6.0

Infant formula powder milk based

12

6.09

0.105

1.7

0.131

2.2

Infant formula powder soy based

12

6.26

0.105

1.7

0.211

3.4

Infant formula RTF milk based

12

9.01

0.168

1.9

0.189

2.1

Adult nutritional RTF high protein

16

9.10

0.283

3.1

0.299

3.3

Adult nutritional RTF high fat

12

10.7

0.120

1.1

0.179

1.7

a

 Results reported as mg/kg powder.

Candidates for 2016 Method of the Year

104